96 related articles for article (PubMed ID: 23360702)
1. Special considerations in the management of older adult patients with metastatic breast cancer.
Donovan D
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():41-8. PubMed ID: 23360702
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer epidemiology and management with a focus on taxanes.
Donovan D
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():5-8. PubMed ID: 23360697
[TBL] [Abstract][Full Text] [Related]
3. Taxanes as a first-line systemic treatment in metastatic breast cancer.
Urquhart LM
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():15-21. PubMed ID: 23360699
[TBL] [Abstract][Full Text] [Related]
4. Evolution of taxanes in the treatment of metastatic breast cancer.
Binder S
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():9-14. PubMed ID: 23360698
[TBL] [Abstract][Full Text] [Related]
5. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
Maxwell C
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
[TBL] [Abstract][Full Text] [Related]
6. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
7. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.
O'Brien ME
Anticancer Drugs; 2008 Jan; 19(1):1-7. PubMed ID: 18043124
[TBL] [Abstract][Full Text] [Related]
8. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
Rivera E
Am J Clin Oncol; 2010 Apr; 33(2):176-85. PubMed ID: 19675449
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO.
Pivot X; Schneeweiss A; Verma S; Thomssen C; Passos-Coelho JL; Benedetti G; Ciruelos E; von Moos R; Chang HT; Duenne AA; Miles DW
Eur J Cancer; 2011 Nov; 47(16):2387-95. PubMed ID: 21757334
[TBL] [Abstract][Full Text] [Related]
10. High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer.
Stemmler J; Mair W; Stauch M; Papke J; Deutsch G; Abenhardt W; Dorn B; Kentenich C; Malekmohammadi M; Jackisch C; Leinung S; Brudler O; Vehling-Kaiser U; Stamp J; Heinemann V
Oncology; 2005; 68(1):71-8. PubMed ID: 15809523
[TBL] [Abstract][Full Text] [Related]
11. Combination versus sequential single-agent therapy in metastatic breast cancer.
Miles D; von Minckwitz G; Seidman AD
Oncologist; 2002; 7 Suppl 6():13-9. PubMed ID: 12454315
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel in the treatment of breast cancer: current experience and future prospects.
Nabholtz JM; Gligorov J
Expert Rev Anticancer Ther; 2005 Aug; 5(4):613-33. PubMed ID: 16111463
[TBL] [Abstract][Full Text] [Related]
13. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
14. A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.
Lissoni P; Bucovec R; Malugani F; Ardizzoia A; Villa S; Gardani GS; Vaghi M; Tancini G
Anticancer Res; 2002; 22(2B):1131-4. PubMed ID: 12168912
[TBL] [Abstract][Full Text] [Related]
15. Metastatic breast cancer: understanding current management options.
McGinn K; Moore J
Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
[TBL] [Abstract][Full Text] [Related]
16. Monotherapy of metastatic breast cancer: a review of newer agents.
Vogel CL; Nabholtz JM
Oncologist; 1999; 4(1):17-33. PubMed ID: 10337368
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer.
Trudeau ME
Semin Oncol; 1999 Jun; 26(3 Suppl 8):21-6. PubMed ID: 10403470
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel and paclitaxel in breast cancer therapy: present status and future prospects.
D'Andrea GM; Seidman AD
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-27-S13-44. PubMed ID: 9335514
[TBL] [Abstract][Full Text] [Related]
19. Taxanes in elderly breast cancer patients.
Wildiers H; Paridaens R
Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA
Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
